HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D.

AbstractBACKGROUND AND AIM:
N-methyl-4-isoleucine cyclosporine (NIM811), a new analogue of cyclosporine A, can inhibit collagen deposition in vitro and reduce liver necrosis in a bile-duct-ligation animal model. However, whether NIM811 effects on CCl(4) -induced rat liver fibrosis, and the related mechanism has not been determined.
METHODS:
A liver fibrosis model was induced in Wistar rats using CCl(4) for 6 weeks. Meanwhile, two different doses of NIM811 (low-dose 10 mg/kg and high-dose 20 mg/kg) were given to the CCl(4) -treated rats. Liver fibrosis was then evaluated according to histopathological scoring and liver hydroxyproline content. Serum alanine aminotransferase, aspartate aminotransferase and albumin levels, expression of matrix metalloproteinase-13, tissue inhibitor of metalloproteinase-1, α-smooth muscle actin and cyclophilin B and D in liver tissue were determined. Cyclophilin B and D were also studied in an hepatic stellate cell line.
RESULTS:
Hydroxyproline content was decreased in both NIM811 groups compared with the model (P < 0.05). Liver necrosis and fibrosis were also attenuated in the NIM811 groups. NIM811 suppressed the expression of tissue inhibitor of metalloproteinase-1, transforming growth factor beta mRNA and α-smooth muscle actin protein in liver tissue. Expression of cyclophilin B in the fibrosis model was increased compared with the normal group (P < 0.05), and was decreased significantly in the low-dose NIM811 treatment group (P < 0.05), which indicated that cyclophilin B might have a profibrotic effect. In vitro studies revealed that cyclophilin B and/or D knockout were associated with collagen inhibition.
CONCLUSIONS:
NIM811 attenuates liver fibrosis in a CCl(4)-induced rat liver fibrosis model, which may be related to binding with cyclophilin B and D.
AuthorsHui Wang, Yuguo Zhang, Tailing Wang, Hong You, Jidong Jia
JournalJournal of gastroenterology and hepatology (J Gastroenterol Hepatol) Vol. 26 Issue 3 Pg. 558-67 (Mar 2011) ISSN: 1440-1746 [Electronic] Australia
PMID21332552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Chemical References
  • Actins
  • Collagen Type III
  • Cyclophilin D
  • RNA, Messenger
  • Serum Albumin
  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta
  • smooth muscle actin, rat
  • cyclophilin B
  • Cyclosporine
  • (melle-4)cyclosporin
  • Carbon Tetrachloride
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat
  • Cyclophilins
  • Hydroxyproline
Topics
  • Actins (metabolism)
  • Alanine Transaminase (blood)
  • Analysis of Variance
  • Animals
  • Aspartate Aminotransferases (blood)
  • Carbon Tetrachloride
  • Cell Line
  • Collagen Type III (genetics)
  • Cyclophilin D
  • Cyclophilins (genetics, metabolism)
  • Cyclosporine (pharmacology)
  • Cytoprotection
  • Dose-Response Relationship, Drug
  • Hepatic Stellate Cells (drug effects, enzymology, pathology)
  • Hydroxyproline (metabolism)
  • Liver (drug effects, enzymology, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, enzymology, genetics, pathology, prevention & control)
  • Male
  • Matrix Metalloproteinase 13 (genetics)
  • RNA Interference
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar
  • Serum Albumin (metabolism)
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-1 (genetics)
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: